Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Delirium predicts 12-month mortality.

Jane McCusker1, Martin Cole, Michal Abrahamowicz

  • 1Department of Clinical Epidemiology and Community Studies, St Mary's Hospital Center, 3830 Lacombe Ave, Room 2508, Montreal, Quebec, Canada H3T 1M5. jane.mccusker@mcgill.qc.ca

Archives of Internal Medicine
|February 28, 2002
PubMed
Summary

Delirium independently predicts increased 12-month mortality in older medical patients. This risk is higher for patients without dementia, with greater symptom severity indicating worse outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pain control following total hip arthroplasty: a prospective randomized controlled trial comparing spinal anaesthesia without adjuncts versus fascia iliaca block versus pericapsular nerve group block versus local anaesthetic infiltration.

Bone & joint open·2026
Same author

HSR26-200: Chronicled Experiences of Breast Cancer: Analysing Adjuvant Endocrine Therapy on TikTok.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Connectome-based spatial statistics enabling large-scale population analyses of human connectome across cohorts.

bioRxiv : the preprint server for biology·2026
Same author

HSR26-200: Chronicled Experiences of Breast Cancer: Analysing Adjuvant Endocrine Therapy on TikTok.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Standing the test of time: diagnostic accuracy of the Edmonton Symptom Assessment System-Revised (ESAS-r) for anxiety and depression screening.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Acceptability of a Digital Care App in Patients Undergoing Hip and Knee Arthroplasty: Prospective Cohort Study.

JMIR human factors·2026

Area of Science:

  • Geriatric Medicine
  • Critical Care Medicine
  • Neuroscience

Background:

  • Previous studies on delirium and mortality had limitations like small sample sizes.
  • Delirium's independent impact on post-discharge mortality requires further investigation.
  • This study addresses confounding factors in older medical inpatients.

Purpose of the Study:

  • To determine the independent effect of delirium on 12-month mortality in older medical inpatients.
  • To investigate the influence of delirium type (incident vs. prevalent) and symptom severity on mortality.
  • To assess the interaction between delirium and dementia on mortality risk.

Main Methods:

  • Prospective, observational study of two cohorts: patients with delirium (n=243) and controls without delirium (n=118).

Related Experiment Videos

  • Inclusion criteria: medical inpatients aged 65 years or older.
  • Statistical analysis using Cox proportional hazards model with covariate adjustment for mortality prediction.
  • Main Results:

    • Delirium was an independent predictor of 12-month mortality (adjusted hazard ratio: 2.11).
    • The association between delirium and mortality persisted throughout the 12-month period.
    • Mortality risk was significantly higher in patients with delirium and without dementia, particularly with greater symptom severity.

    Conclusions:

    • Delirium is a significant independent prognostic marker for increased 12-month mortality in older medical inpatients.
    • Delirium's prognostic value is particularly pronounced in patients without co-existing dementia.
    • Severity of delirium symptoms is associated with mortality risk, especially in non-demented patients.